Your browser doesn't support javascript.
loading
Bendamustine, followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia (CLL2-BIO): primary endpoint analysis of a multicenter, open-label phase-II trial.
Cramer, Paula; Tresckow, Julia V; Robrecht, Sandra; Bahlo, Jasmin; Fürstenau, Moritz; Langerbeins, Petra; Pflug, Natali; Al-Sawaf, Othman; Heinz, Werner J; Vehling-Kaiser, Ursula; Dürig, Jan; Tausch, Eugen; Hensel, Manfred; Sasse, Stephanie; Fink, Anna-Maria; Fischer, Kirsten; Kreuzer, Karl-Anton; Böttcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael.
  • Cramer P; University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany.
  • Tresckow JV; University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany.
  • Robrecht S; University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany.
  • Bahlo J; University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany.
  • Fürstenau M; University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany.
  • Langerbeins P; University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany.
  • Pflug N; University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany.
  • Al-Sawaf O; University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany.
  • Heinz WJ; University of Würzburg, Medical Center, Medical Clinic II, Würzburg, Germany.
  • Vehling-Kaiser U; Tagesklinik Landshut, Landshut, Germany.
  • Dürig J; University Hospital Essen, Department for Hematology, West German Cancer Center, Essen, Germany.
  • Tausch E; Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany.
  • Hensel M; Mannheimer Onkologie Praxis, Mannheim, Germany.
  • Sasse S; University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany.
  • Fink AM; University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany.
  • Fischer K; University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany.
  • Kreuzer KA; University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany.
  • Böttcher S; Department III of Internal Medicine, Rostock University Medical Center, Rostock, Germany.
  • Ritgen M; Department of Internal Medicine II, Campus Kiel, University of Schleswig-Holstein, Kiel, Germany.
  • Kneba M; Department of Internal Medicine II, Campus Kiel, University of Schleswig-Holstein, Kiel, Germany.
  • Wendtner CM; Department of Hematology, Oncology, Immunology, Klinikum Schwabing, Munich, Germany.
  • Stilgenbauer S; Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany.
  • Eichhorst B; University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany.
  • Hallek M; University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany.
Haematologica ; 106(2): 543-554, 2021 02 01.
Article en En | MEDLINE | ID: mdl-32107341
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article